Recent Quotes
View Full List
My Watchlist
A.P Moller-Mrs ADR
Frontdoor, Inc. - Common Stock
Talon Metals Corp
Well Health Technologies Corp
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Ellipses Pharma Limited
Ellipses Pharma explores a London Stock Exchange listing opportunity
November 18, 2026
From
Ellipses Pharma Limited
Via
Business Wire
Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China
January 22, 2026
From
Ellipses Pharma Limited
Via
Business Wire
Ellipses In-Licences First in Class Novel Immuno-Oncology Agent With Potential as a Next Generation Checkpoint Inhibitor
February 11, 2025
From
Ellipses Pharma Limited
Via
Business Wire
Ellipses Launches Pioneering Clinical Trial Programme in Middle East
December 23, 2024
From
Ellipses Pharma Limited
Via
Business Wire
Ellipses Pharma Presents Preliminary Data From the First in Human Phase-1/2 Trial of EP0042, a Dual FLT-3 and Aurora Kinase Inhibitor, at ASH
December 12, 2022
From
Ellipses Pharma Limited
Via
Business Wire
Ellipses Pharma Presents Design of Newly Initiated Phase 1/2a Trial of Vosilasarm (EP0062) at SABCS
December 05, 2022
From
Ellipses Pharma Limited
Via
Business Wire
Ellipses Pharma to Present Clinical Updates at Leading U.S. Breast and Blood Cancer Conferences
November 21, 2022
From
Ellipses Pharma Limited
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.